TSN: EU: COVID-19 Vax Adverse Reaction Study—500% Increase of Incidence Reported First Half of 2021

Credit to TrialSite News

In Slovakia, a team of researchers with expertise in clinical pharmacology analyzed data associated with spontaneous reports of suspected adverse reactions post-administration with COVID-19 vaccines. Represented by Stefan Lassan, corresponding author affiliated with Slovak Medical University, and Bratislava University Hospital, both in Slovakia, and colleagues had their findings published earlier in the year in the peer review journal Frontiers Pharmacology. This study looks into COVID-19 vaccination rates in the Slovak Republic, where the vaccination rate was at 58%, well below the target below the World Health Organization's targeted 70%. One of the key reasons for hesitancy in this Eastern European nation: concern about serious adverse events. Thus, the importance of this study is to review the incidence of reported adverse reactions of authorized COVID-19 vaccines which in Slovakia include Comirnaty (Pfizer); Vaxzervia (AstraZeneca), and Spikevax (Moderna) registered with the State Institute for Drug Control between January 1, 2021, and May 31, 2021. Conducting this retrospective analysis, the researchers report on this first analysis targeting the nation of Slovakia involving the incidence of reported adverse reactions associated with COVID-19 vaccines. While tracking spontaneous adverse events has been difficult, given the call for reporting on such events during the study time period, the study authors report a significant increase in such reports—a five-fold increase in vaccine-related incidents in just the first half of 2021. The AstraZeneca jab was associated with the highest rate of suspicious serious adverse reactions.
------------------------------------
Join The Conversation! | https://trialsitenews.com/